Skip to main content
35°
Cloudy
Site search
Search
Menu
Search
Subscribe
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
Contact Us
Subscribe
News
East Greenwich Pendulum
Kent County Daily Times
Narragansett Times
NK Standard-Times
Sports
Features
Special Sections
Local Guide
Local Events
Markets & Stocks
Weather
League of Women Voters SRI
League of Women Voters WS
Classifieds
Place ad
Business Service Directory
Legal Notices
Place Kent Legal
Place SRI Class Legal
Search SRI Legals
Search Kent Legals
Obituaries
Subscribe
E-Edition
Community Choice
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
MannKind Corporation - Common Stock
(NQ:
MNKD
)
5.420
-0.130 (-2.34%)
Streaming Delayed Price
Updated: 4:00 PM EST, Feb 14, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about MannKind Corporation - Common Stock
< Previous
1
2
3
4
5
6
7
Next >
MannKind Corporation to Hold 2023 First Quarter Financial Results Conference Call on May 9, 2023
May 02, 2023
From
MannKind
Via
GlobeNewswire
Why Nevro Shares Are Trading Lower By Around 19%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
April 20, 2023
Gainers Aditxt, Inc. (NASDAQ: ADTX) shares gained 68.6% to $1.45. Aditxt signed asset purchase agreement to acquire 50% ownership of Global Response Aid with rights to manufacture and market...
Via
Benzinga
Looking Into MannKind's Return On Capital Employed
February 27, 2023
Via
Benzinga
MannKind (MNKD) Q4 2022 Earnings Call Transcript
February 24, 2023
MNKD earnings call for the period ending December 31, 2022.
Via
The Motley Fool
MannKind Earnings Preview
February 22, 2023
Via
Benzinga
Cleveland-Cliffs: A Steel Producer To Target In This Resilient Market
April 16, 2023
One of the nice things about “boring” markets is that they do not require a lot of “rethinking of things,” and given just how resilient this market has been in the face of all that has been thrown at...
Via
Talk Markets
Lauren Sabella Joins Mannkind as Executive Vice President, Chief Operating Officer
March 27, 2023
From
MannKind
Via
GlobeNewswire
MannKind Corporation to Participate in Oppenheimer 33rd Annual Healthcare Conference
March 07, 2023
From
MannKind
Via
GlobeNewswire
MannKind To Rally Around 30%? Here Are 10 Other Analyst Forecasts For Monday
February 27, 2023
Piper Sandler cut the price target for CS Disco, Inc. (NYSE: LAW) from $11 to $7.5. Piper Sandler analyst Arvind Ramnani downgraded the stock from Overweight to Neutral. CS Disco shares fell 1.2% to...
Via
Benzinga
MannKind's Return On Capital Employed Overview
December 05, 2022
Via
Benzinga
MannKind Corporation (MNKD) Q3 2022 Earnings Call Transcript
November 08, 2022
MNKD earnings call for the period ending September 30, 2022.
Via
The Motley Fool
Kratos Defense & Security, Zeta Global, Beacon Roofing Supply And Other Big Stocks Moving Higher On Friday
February 24, 2023
U.S. stocks traded lower, with the Dow Jones dropping more than 400 points on Friday. Here are some big stocks recording gains in today’s session.
Via
Benzinga
MannKind Corporation Reports 2022 Fourth Quarter and Full Year Financial Results
February 23, 2023
Conference Call to Begin Today at 5:00 p.m. (ET)
From
MannKind
Via
GlobeNewswire
MannKind to Give Oral Presentation on Meal Challenge Results From the Afrezza® With Basal Combination (ABC Study) at 16th Annual ATTD Conference
February 22, 2023
From
MannKind
Via
GlobeNewswire
Earnings Scheduled For February 23, 2023
February 23, 2023
Companies Reporting Before The Bell • ChipMOS TECHNOLOGIES (NASDAQ:IMOS) is likely to report earnings for its fourth quarter.
Via
Benzinga
MannKind Corporation to Hold 2022 Fourth Quarter and Full Year Financial Results Conference Call on February 23, 2023
February 16, 2023
From
MannKind
Via
GlobeNewswire
Mannkind Corporation to Participate in the SVB Securities Global Biopharma Conference
February 10, 2023
From
MannKind
Via
GlobeNewswire
MannKind Corporation to Participate in the Lytham Partners Investor Select Conference
January 24, 2023
From
MannKind
Via
GlobeNewswire
MannKind’s Inhaled Clofazimine Will Advance to an Adaptive Phase 2/3 Study For Potential Treatment of Rare Lung Disease
January 23, 2023
From
MannKind
Via
GlobeNewswire
3 Biotech Stocks Under $15 Worth a Second Look in 2023
January 18, 2023
All three stocks have promising therapies that could drive revenue in the coming years.
Via
The Motley Fool
MannKind Corporation to Present at 2023 Annual J.P. Morgan Healthcare Conference
January 05, 2023
From
MannKind
Via
GlobeNewswire
MannKind to Present Two Posters at 22nd Annual Diabetes Technology Meeting
November 10, 2022
From
MannKind
Via
GlobeNewswire
MannKind To Rally 57%? Here Are 5 Other Price Target Changes For Wednesday
November 09, 2022
Via
Benzinga
Tyson Foods To $61? Plus Needham Slashes PT On This Stock By 33%
November 09, 2022
B of A Securities cut the price target on Tyson Foods, Inc. (NYSE: TSN) from $73 to $61. Tyson Foods shares fell 1.9% to $66.44 in pre-market trading.
Via
Benzinga
MannKind Corporation Reports 2022 Third Quarter Financial Results
November 08, 2022
Conference Call to Begin Today at 9:00 a.m. (ET)
From
MannKind
Via
GlobeNewswire
Earnings Preview: MannKind
November 07, 2022
MannKind (NASDAQ:MNKD) is set to give its latest quarterly earnings report on Tuesday, 2022-11-08. Here's what investors need to know before the announcement. Analysts estimate that MannKind will...
Via
Benzinga
MannKind Corporation to Hold 2022 Third Quarter Financial Results Conference Call on November 8, 2022
November 01, 2022
From
MannKind
Via
GlobeNewswire
7 Penny Sleeper Stocks to Buy Before Wall Street Wakes Up
September 29, 2022
While these market ideas are risky, they offer enough relevance to be intriguing.
Via
InvestorPlace
7 Penny Stocks That Actually Have a Buy Rating
September 19, 2022
Penny stocks are always a risky proposition. However, investors can still find penny stocks with buy ratings right now.
Via
InvestorPlace
MannKind Shares Fall After Completing Initial Stage Lung Disease Study
September 06, 2022
MannKind Corporation (NASDAQ: MNKD) has successfully completed a Phase 1 study of clofazimine inhalation suspension (MNKD 101), an inhalation treatment option for nontuberculous mycobacterial (NTM)...
Via
Benzinga
< Previous
1
2
3
4
5
6
7
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.